Skip to main content
pCPA File Number:
21102
Negotiation Status:
Concluded with an LOI
Indication(s):
renal cell carcinoma
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals
CADTH Project Number:
pCODR 10163
pCPA Engagement Letter Issued:
Negotiation Process Concluded: